Li Chen

8PUBLICATIONS
143CO-AUTHORS
Molecular targetsHaematological tumoursSoftware quality, processes and metricsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 17, 2026
Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

|Mar 17, 2026
Dynamic switching of apoptosis-modulating BIM heterodimers in response to BH3 mimetics in xenograft models of hematologic malignancies.

Jeevan Prasaad Govindharajulu, Sharon Fluss, Melinda G Hollingshead

|Feb 19, 2026
Endosialin (CD248) Cancer Role and Therapeutics: 33 Years on.

Beverly A Teicher, Li Chen, Dianne L Newton

|Nov 06, 2025
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials.

Cloud P Paweletz, Thomas D Forbes, Laura Yee

|Oct 09, 2025
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

Anne S Tsao, Zihe Song, Alan L Ho

|Feb 11, 2025
Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors.

Amy L Funk, Meghri Katerji, Marwa Afifi

Pageof 2

Frequent Collaborators

3 joint publications

Stanley R Hamilton

3 joint publications

David R Patton

3 joint publications

James H Doroshow

3 joint publications

Peter J O'Dwyer